The DNA repair protein O 6 -methylguanine-DNA methyltransferase (MGMT) is inducible by genotoxic stress. MGMT induction results from transcriptional activation of the MGMT gene which is a speci®c response to DNA damage. A possible factor involved in triggering MGMT induction might be p53, because both p53 and MGMT are activated by DNA breaks. To study the eect of p53 on induction of the MGMT gene, we compared the presence of functional wild-type (wt) and mutant p53 with MGMT expression level in various mouse ®broblasts and rat hepatoma cell lines upon genotoxic treatment. Cells which responded to ionizing radiation (IR) by MGMT induction displayed functional p53, whereas in cells not expressing wt p53, MGMT induction was not observed. Also, the cloned MGMT promoter was inducible by IR upon transfection into p53 wt cells, but not in cells de®cient for p53. Thus, expression of wt p53 appears to be required for induction of MGMT mRNA and protein by IR. On the other hand, transfection of a MGMT-promoter-CAT construct together with p53 (either wt or mutant) in cells expressing wt p53 markedly reduced the basal activity of the MGMT promoter whereas cotransfection with a p53 antisense construct slightly increased MGMT promoter activity. Furthermore, cotransfection of MGMT promoter with wt or mutant p53 in p53 wt cells reduced radiation evoked MGMT promoter induction. Thus, transfection mediated high level expression of p53 has inhibitory eect both on basal MGMT promoter activity and its activation by IR. The results give evidence for involvement of p53 in DNA damage-induced MGMT promoter activation.
Introduction
Expression of the DNA repair protein O 6 -methylguanine-DNA methyltransferase (MGMT, E.C.2.1.1.63; also known as alkyltransferase) plays a decisive role in protection of cells and individuals against the toxic, mutagenic and carcinogenic eects of alkylating environmental DNA damaging agents and cytostatic drugs inducing alkyl groups at the O 6 -position of guanine (D'Incalci et al., 1988; Pegg, 1990; Mitra and Kaina, 1993; Margison et al., 1996) . Thus, MGMT de®cient cells show reduced survival and enhanced mutation and aberration frequencies after alkylation, as compared to MGMT expressing cells (for review see Kaina et al., 1993) . Also, transgenic mice which overexpress MGMT in thymus or liver are less susceptible to tumor formation after methylating treatment than control animals (Dumenco et al., 1993; Nakatsuru et al., 1993) , and expression of human MGMT in skin of mice eectively protected them against skin tumor development after low-dose treatment with methylnitrosourea and the antineoplastic drug nimustine (ACNU), using the two-stage tumor initiation-promotion protocol (Becker et al., 1996 (Becker et al., , 1997 .
MGMT expression is inducible in rat, mouse and human cells by a variety of DNA damaging treatments which was shown with cells cultivated in vitro (Laval, 1990 (Laval, , 1991 Fritz et al., 1991; Fukuhara et al., 1992; Chan et al., 1992; Fritz and Kaina, 1992; Lefebvre et al., 1993; Grombacher et al., 1996) as well as under in vivo conditions (Schmerold and Wiestler, 1986; Chan et al., 1990; Wilson et al., 1993; Raerty et al., 1996) . Induction level of MGMT activity is in the range of 2 ± 5-fold in vitro and up to 20-fold in rat liver in vivo. The observed increases in MGMT protein and repair activity upon genotoxic treatment are due to stimulation of MGMT gene expression, which was shown by using transcriptional inhibitors and in experiments with the cloned MGMT promoter (Grombacher et al., 1996) .
There is experimental evidence supporting the view that the primary cellular signal for induction of MGMT expression is DNA damage, notably DNA strand breaks. It is based on the following ®ndings: (i) a broad spectrum of DNA damaging agents including alkylating agents, ionizing radiation (IR) and ultraviolet (UV) light, having in common to induce DNA breaks, is able to induce MGMT; (ii) MGMT expression can be induced in cells in which restriction endonucleases were brought in by electroporation (Laval, 1990; Fritz and Kaina, 1992) ; (iii) inhibition of poly(ADP)ribosyltransferase (PARP) which binds and thereby masks free DNA ends enhances MGMT induction by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) (Laval, 1990) ; (iv) MGMT induction occurs faster after treatment with IR as compared to MNNG (Grombacher et al., 1996) which might be due to the fact that IR induces immediately DNA strand breaks whereas, for MNNG, they result from DNA replication or incomplete DNA repair.
An induction pro®le very similar to MGMT has been found for the tumor suppressor protein p53. The p53 protein level is enhanced by a variety of DNA damaging agents having in common to induce DNA breaks. Furthermore, p53 was shown to be inducible by IR and by electroporation of restriction endonucleases inducing DNA strand breaks (Nelson and Kastan, 1994; Levine, 1997) . Similar to MGMT, induction of p53 by treatment of cells with IR occurs faster as compared to MNNG or UV light (Lu and Lane, 1993) .
The regulatory function of p53 on various cellular processes is mediated, at least in part, by its action as a sequence speci®c transcription factor (Levine, 1997) . Examples of this are transcriptional activation of p21, whose expression plays a decisive role in regulation of the cell cycle (Liebermann et al., 1995) , and transactivation of proliferating cell nuclear antigene (PCNA) which is a cofactor of DNA polymerase d and e and thus involved in DNA replication and repair (Prelich et al., 1987; Shivji et al., 1992; Kelman, 1997) . A couple of other genes are known to be activated by p53, such as mdm2, gadd 45, cyclin G, bax and IGF-BP 3 (Levine, 1997) .
Besides activation of genes, p53 also in¯uences cellular processes by direct protein-protein interaction. Interactions of proteins with p53 have been described for basal transcription factors (TFIID, TBP, TFIIH, Sp1, CBP) and for some cellular (MDM2, cAbl) and viral (SV40Tag, AdE1B, HPVE6) proteins (Levine, 1997) . The fact that p53 is able to repress speci®cally the expression of certain genes without binding to their promoters has lead to the assumption that this repression is mediated through direct interaction with the basal transcription machinery (Seto et al., 1992; Farmer et al., 1996) .
Because of the similarity in induction of MGMT and p53 protein upon genotoxic exposure and taking into account the regulatory eect of p53 on promoter activities, it would be reasonable to hypothesize that p53 is part of the signal transduction pathway eliciting MGMT gene induction upon genotoxic stress. First data in line with this hypothesis were obtained from mice, showing that MGMT induction by whole-body irradiation did not occur in animals de®cient in p53 (Raerty et al., 1996) . To investigate the dependence of MGMT induction on p53 expression in more detail, we analysed the p53 status of dierent mouse and rat cell lines and compared it with the inducibility of MGMT by IR. Moreover, we carried out studies with the human MGMT promoter to elucidate whether the eect of p53 on MGMT induction was caused by p53-mediated alteration in transcriptional activity of the MGMT gene.
Results

Induction of MGMT expression in mouse ®broblasts with or without functional p53
First, we investigated the inducibility of MGMT in ®ve mouse ®broblast cell lines diering in their p53 status. Cell lines BK2, BK4 and ®b2 express wild-type p53: they showed a characteristic increase in the amount of p53 protein after genotoxic treatment, caused by stabilization of the protein ( Figure 1A ). The functionality of the induced p53 in these lines was veri®ed by showing p53 dependent induction of p21 expression ( Figure 1A ). The cell lines BK1 and ®b1, which were established from tissue of p53 knockout mice, did neither show p53 expression nor p21 induction these cells are clearly p53 de®cient. Both the basal level and the inducibility of MGMT by IR which is a potent inducer of MGMT was investigated in these ®ve cell lines. In BK2, BK4 and ®b2 cells expressing wild-type p53, MGMT mRNA ( Figure 1B ) and MGMT activity (Table 1) was enhanced 2 ± 5-fold after irradiation. This was comparable to the induction level of MGMT activity observed previously with other responsive systems (Grombacher et al., 1995) . In contrast, under the same conditions of treatment with IR, in the p53 de®cient cell lines BK1 and ®b1 neither MGMT mRNA expression nor MGMT activity was found to be enhanced ( Figure  1B and Table 1 ).
H5 rat hepatoma cells defective in MGMT induction lack functional p53
In dierentiated rat liver cells MGMT expression is inducible by genotoxic treatments, which is shown here + mRNA, which was transfered onto a nylon membrane, using human MGMT cDNA as a probe. RNA was prepared 24 h after irradiation with 10 Gy of g-rays. For quantitation, the ®lter was rehybridized with glyceraldehyde phosphodehydrogenase (GAPDH) which is not inducible by DNA damage (Grombacher et al., 1996) . Because of low level expression, signals for ®b2 MGMT mRNA were detected after longer exposure time. Induction was set in relation to GAPDH, and the non-irradiated control, which was between 1.5-and 5-fold for BK2, BK4 and ®b2. The induction factor (MGMT/GAPDH) for BK1 and ®b1 was 1 and 0,5 respectively for the rat hepatoma cell line H4IIE. MGMT activity was raised in these cells signi®cantly after treatment with IR or MNNG (Table 1 and data not shown), and also MGMT mRNA expression was enhanced ( Figure 2A ). Induction of MGMT mRNA and protein activity was not found in the dedierentiated hepatoma cell line H5. We examined the p53 status of both cell lines which dier markedly in their MGMT inducibility. It turned out that H5 cells constitutively express p53 to high level which could not further be enhanced by treatment with IR or MNNG ( Figure 2B ). The constitutively enhanced p53 level very likely results from stabilization of the p53 protein which is characteristic for the mutant form of p53. That H5 cells do not express functional p53 is further indicated by loss of p53 dependent induction of p21 ( Figure 2B ) and the absence of cell cycle blockage at the border of G1/S-phase upon IR ( Figure 2C ) which is characteristic for mutant p53 expressing cells. In contrast, H4IIE rat hepatoma cells competent in inducing MGMT expression showed p53 to be inducible by MNNG and IR ( Figure 2B ). Moreover, after IR and MNNG treatment p21 protein level was enhanced in these cells, and IR also lead to cell cyle arrest at the G1/Sborder ( Figure 2C ) indicating that H4IIE cells indeed express functional p53.
The inducibility of human MGMT promoter is related to normal p53 status
The human MGMT promoter is inducible by IR (see Figures 3 and 4) . However, induction of the MGMT promoter which was transfected (as MGMT-promoter-CAT construct) into rat and mouse cells was dependent on normal p53 expression in these cells. Thus, the induction factor was 3.8-fold and 3.5-fold for ®b2-and H4IIE-cells, respectively. In BK1 mouse ®broblasts and H5 rat hepatoma cells, which do not express functional p53, induction of the transfected MGMT promoter by IR was abrogated (Figure 3 ). Similar to the basal MGMT promoter activity, there was a remarkable in¯uence of cotransfected p53 expression constructs on the inducibility of the MGMT promoter by IR. In the wild-type p53 expressing cell lines H4IIE and ®b2, cotransfection of the MGMT promoter with either wild-type, mutant or antisense p53 expression vector signi®cantly reduced inducibility by IR from 3.5-and 3.8-fold to a level which was between 1.2-and 1.9-fold, respectively (Figure 4a and b) . In the p53 de®cient cell line BK1, cotransfection of MGMT promoter with wild-type p53 also resulted in decrease of basal MGMT promoter activity, whereas a slight (non-signi®cant) enhancement of MGMT promoter activity by treatment with IR was observed (1.8-fold), as compared to the same cells transfected with MGMT promoter-CAT together with carrier DNA (1.3-fold) (Figure 4c ). Cotransfection of either the antisense or the mutated p53 expression construct had no eect on MGMT promoter induction in these cells (data not shown).
Discussion p53 is a sequence speci®c transcription factor involved in transactivation of various genes after the induction of DNA damage. One of them is p21, which is involved in cell cycle blockage at the G1/S border thus protecting cells against DNA damaging agents by extenting the time of prereplicative DNA repair (Pellegata et al., 1996) . Besides a function in cell cycle regulation, p53 plays an important role in the Figure 3 Inducibility by ionizing radiation (IR) of the human MGMT promoter in cells with or without normal p53 status. Transient transfections with 10 mg of the human MGMT promoter-CAT construct were performed in ®b2-, BK1-, H4IIE-and H5-cells. The amount of CAT protein was determined in control and irradiated cells 48 h after irradiation with 10 Gy of grays (72 h after transfection). Induction factors were calculated relative to the untreated control. Expression data are the mean of at least three independent transfection experiments and CAT determinations. Statistically signi®cant increases in MGMT promoter activity in irradiated versus non-irradiated cells (P50.05) are marked by asterisk Figure 4 In¯uence of cotransfection of dierent p53 expression constructs on basal activity and induction of the human MGMT promoter. Transient cotransfection experiments in H4IIE, ®b2 and BK1 cells were perfomed with 10 mg of the human MGMT promoter-CAT construct together with 10 mg of one of the p53 expression plasmids. Tweny-four hours later, the transfected cells were irradiated with 10 Gy of g-rays or mock treated. Forty-eight hours later, irradiated and non-irradiated cells were harvested and the amount of CAT protein was determined. Induction factors were calculated relative to the untreated control. CAT protein levels are the mean of at least three independent transfection experiments. Statistically signi®cant increases in MGMT promoter activity in irradiated versus non-irradiated cells (P50.05) are marked by asterisk induction of apoptosis after DNA damage by acting as transactivator of bax and Gadd45 and as repressor of genes like bcl-2 and c-myc (Liebermann et al., 1995) . Largely unclear is the role of p53 in regulation of DNA repair genes after damaging the DNA. An indirect in¯uence on DNA repair processes could be executed by p53 via the control of PCNA, Gadd45 and p21 expression. PCNA is a cofactor of DNA polymerases d and e and participates in nucleotide excision repair and mismatch repair (Kelman, 1997) . p53 binds to promoter sequences of the PCNA gene and activates its expression (Shivakumar et al., 1995) . Furthermore, p53 regulates the expression of Gadd45 and p21 which, by protein-protein interaction with PCNA, may regulate DNA repair processes indirectly (Liebermann et al., 1995; Wood, 1997) . The requirement of wild-type p53 expression for ecient nucleotide excision repair in human ®broblasts has been shown recently. Using p53 de®cient human ®broblasts stably transfected with an inducible p53 expression vector, the authors showed that nucleotide excision repair is enhanced upon expression of p53 in the de®cient line (Ford and Hanawalt, 1997) .
Here we show that p53 is involved in regulation of the DNA repair gene MGMT. The eect of p53 on MGMT expression appears to be dual and related to both basal MGMT expression and its induction by genotoxic stress. As showed here and previously by another group (Harris et al., 1996) , p53 suppresses basal MGMT promoter activity when overexpressed in cells upon transfection with p53 expression vector. This eect of p53 appears to be executed without binding of the protein to the MGMT promoter (T Grombacher and B Kaina, unpublished data). p53 mediated repression of promoter activity has been described also for various other genes having no p53 binding site in their promoter region (Ginsberg et al., 1991; Subler et al., 1992) . The detailed mechanism behind this phenomenon is unknown. DNA binding and transactivation capabilities of p53 seem not to be required for this since mutated p53 proteins, which are defect in both activities, retained the ability to repress promoter activity (Farmer et al., 1996) . In our experiments, expression of mutant (Val 143?Ala) p53 which has no DNA binding activity gave rise to repression of basal MGMT promoter activity similar to the eect observed with wild-type p53 transfection. In experiments performed by others (Harris et al., 1996) , reduction by 20% of the basal expression of MGMT promoter activity upon coexpression of this mutant form of p53 was found. The slightly dierent quantitative inhibitory eects observed might be related to various expression levels of the mutant p53 protein. We should note that the eect of repression of the MGMT promoter by p53, which was observed reproducibly in cotransfection experiments with p53 and MGMT promoter, must not necessary re¯ect the normal cellular situation since, upon transfection, p53 might be expressed at unphysiologically high level. Comparing the basal MGMT level of cell lines used in this study and also of mice which are p53 de®cient versus mice which have normal p53 phenotype (Raerty et al., 1996) it becomes obvious that basal MGMT expression is not clearly related to the p53 status of cells or individuals. Thus, p53 de®cient and p53 mutant cells express MGMT to a level comparable to wild-type p53 expressing cells. This has also been shown in mice where basal expression of MGMT activity in liver, lung, kidney and brain was similar in wild-type and p53 lacking individuals (Raerty et al., 1996) .
A more signi®cant eect is exerted by p53 on the induction of the MGMT gene by DNA damaging agents. We show here that MGMT mRNA and protein become induced by IR only in wild-type p53 expressing cells of mice and rat. In cells de®cient for p53 (which were derived from p53 knockout mice) or expressing mutant form of p53, IR did not induce MGMT. These results obtained with in vitro cultivated cells basically con®rm and extend a previous report with p53 knockout mice, showing that MGMT induction in vivo is related to the wild-type status of p53 (Raerty et al., 1996) . The eect of p53 on MGMT induction by IR is mediated by MGMT promoter activation. Thus, transfection of MGMT promoter-CAT into cells expressing wild-type p53 followed by irradiation of the cells gave rise to MGMT promoter activation, whereas transfection of the same construct into p53 de®cient cells and in those expressing mutant p53 did not yield MGMT promoter activation following irradiation. These data clearly establish a requirement of p53 for MGMT promoter activation. On the other hand, if the MGMT promoter was cotransfected with p53 expression plasmid in p53 wild-type expressing cells (rat H4IIE cells and mouse ®broblasts), which were subsequently irradiated, induction of the transfected MGMT promoter was largely reduced. However, under these conditions the basal activity of the MGMT promoter was also strongly depressed. Therefore, the less ecient induction of MGMT observed after cotransfection with p53 is very likely due to the strong suppressive eect exerted by p53 (if expressed at very high level after transfection) on the basal transcription machinery which might interfere with the process of IR-induced transcriptional stimulation of the MGMT gene.
Regarding the possible interaction of p53 with basal transcription factors involved in regulation of MGMT, Sp1 may play a role. The transcription factor was shown to bind p53 (Borellini and Glazer, 1993; Gualberto and Baldwin, 1995) , and the MGMT promoter contains several putative Sp1 binding sites (Harris et al., 1992) . Sp1 sites are often found in promoters of housekeeping genes, indicating that Sp1 plays a role in regulating basal promoter activity. Recently it was shown that Sp1 is also involved in gene induction (Yurochko et al., 1997) . Although the detailed elements of signaling leading to MGMT induction upon genotoxic stress are unknown, the data reported here indicate that p53 plays a decisive role in MGMT gene induction after the generation of DNA damage. MGMT appears to be the ®rst DNA repair gene for which p53 has been demonstrated to in¯uence DNA repair by modulating its expression upon exposure of cells to DNA damaging treatments. Bearing in mind the important role of MGMT in defense against the mutagenic, genotoxic and carcinogenic eects of many environmental carcinogens and also of cytostatic drugs, the involvement of p53 in the regulation of this repair gene may have impact on susceptibility of individuals to carcinogenic exposures as well as tumor therapy.
Materials and methods
Vectors
Cloning of hMGMT (2.6 kb SstI/SstI fragment)-Cat reporter gene construct used in transient transfection experiments was reported previously (Harris et al., 1991) . The plasmid was kindly provided by Dr S Mitra, Galveston. The wild-type p53 expression plasmid was constructed by inserting a 2 kb fragment of human p53 cDNA behind the CMV promoter. The antisense p53 expression vector has been constructed essentially in the same way except that cloning of the p53 cDNA was in antisense orientation. For expressing the mutant form of p53, codon Val 143 (GTG) was mutated to GCG, which codes for Ala (Slingerland et al., 1993) .
Cell lines
BK2, BK4 and ®b2 (p53+/+) cell lines are established mouse 3T3-like ®broblasts derived from newborn wild-type mice. BK1 cell line was established in the same way from p53(7/7) knockout mice (The Jackson Laboratories, Maine). ®b1 cells (p537/7) were a kind gift of A Balmain (Glasgow). All mouse ®broblast lines were grown in DMEM suplemented with 10% inactivated fetal calf serum (FCS). H4IIE and H5 rat hepatoma cell lines have been described previously (Grombacher and Kaina, 1995) . H5 cells were cultivated in F10/DMEM (1 : 1) suplemented with 10% FCS, and H4IIE cells were cultivated in a-MEM with 5% FCS.
MGMT assay
MGMT activity was determined as described (Grombacher and Kaina, 1995) . In brief, cell extracts (100 mg of protein) were incubated together with 100 000 c.p.m. of 3 H-MNU labeled DNA. TCA precipitable, acid hydrolysis (958C) stable fractions containing the protein were recovered and radioactivity of the fractions were determined. The amount of MGMT in cell extracts was calculated from the speci®c activity of the substrate and the amount of radioactivity transfered from DNA to the protein.
Northern hybridization
Northern hybridization using radioactive labeled human MGMT cDNA as a probe was performed as described previously . As a loading control, ®lters were rehybridized with GAPDH cDNA.
Nuclear extract and Western blots
Nuclear extracts were prepared from exponentially growing cells. Cells were collected by centrifugation and washed two times with PBS. Cell pellets were than resuspended in NP40-lysis buer (10 mM Tris pH 7.4, 10 mM NaCl, 3 mM MgCl 2 , 0.5% NP40) and cell membranes were lysed 5 min on ice. The cell nuclei were collected by low speed centrifugation (5 min, 1000 g) and washed once in lysis buer without NP40. Finally, nuclei were resuspended in protein extraction buer (100 mM NaCl, 50 mM Tris pH 7, 2 mM EDTA, 1 mM DTT, 1 mM PMSF) and disrupted by soni®cation. Nuclear debris was removed by centifugation and protein content of the supernants were quanti®ed as described (Bradford, 1976) . 50 mg of nuclear protein were seperated on a 7.5% SDS ± PAGE and than electroblotted onto nitrocellulose membrane (Schleicher and SchuÈ ll, Germany). Amounts of protein on the membrane corresponding to the dierent lanes of the gel were checked by staining the protein with Ponceau S-red. The membrane was blocked overnight against unspeci®c binding of antibodies with 5% non-fat dry milk in PBS, 0,2% Tween-20. Mouse anti-p53 antibody (PAb 240, Neo Markers) diluted 1 : 500, or rabbit anti-p21 antibody (Ab-2, Oncogene Science) diluted 1 : 200 in blocking solution were added. After 1 h of incubation, membranes were extensively rinsed with PBS, 0.2% Tween-20. Thereafter the membranes were incubated with peroxidase-conjugated secondary antibodies diluted in blocking solution (1 : 3000) for 1 h. Finally, membranes were again washed extensively with PBS, 0.2% Tween-20 and membranebound antibodies were visualised by ECL (Amersham) according to the manufacturers protocol.
BrdU pulse labeling and¯ow cytometry analysis
Cell cycle distribution and cell populations after irradiation was determined by measuring both DNA synthesis and DNA content as previously described . In brief, exponentially growing cells were pulse-labeled for 30 min with 10 mM BrdU. Then the medium was removed and the cells were harvested by trypsinization. After extensive washing with PBS, the cells were resuspended in 300 ml PBS and ®xed with 70% ice-cold ethanol overnight at 7208C. For immunodetection of incorporated BrdU, cells were incubated with 2 N HCl for 30 min at 378C, washed two times with PBS, and than resuspended in PBT buer (PBS, 1% BSA, 0.5% Triton X-100) containinḡ ourescein-isothiocyanate (FITC)-conjugated anti BrdU antibody (Becton Dickinson; 1 : 10 diluted). After washing once in PBS, the cells were incubated with 100 mg/ml RNase and 20 mg/ml propidium iodide for DNA quantitation. The intensity of¯ouresceine and propidium iodide staining of 10 000 cells was analysed in a FACSort cytometer (Becton Dickinson) using a computer-based analysis program (CellQuest, Becton Dickinson).
Transfection of cells and CAT assay
Cells were transfected by calcium phosphate coprecipitation as described . Usually, 10 mg of plasmid was used. Sheared salmon sperm DNA was used as carrier, to adjust the amount of DNA to 20 mg per ml of transfection buer. Chloramphenicol acetyltransferase (CAT) assays were perfomed by CAT ELISA (Boehringer Mannheim, Germany) according to the manufacturers protocol as previously described (Grombacher et al., 1996) . MGMT promoter activities in control and irradiated cells were compared statistically for each cell line and each of the p53 cotransfection experiments, using the paired t-test.
